# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-069396
Filing Date
2025-05-12
Accepted
2025-05-12 16:50:40
Documents
82
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | agen-20250331.htm iXBRL | 10-Q | 1992770
2 | EX-31.1 | agen-ex31_1.htm | EX-31.1 | 16924
3 | EX-31.2 | agen-ex31_2.htm | EX-31.2 | 17013
4 | EX-32.1 | agen-ex32_1.htm | EX-32.1 | 11653
| Complete submission text file | 0000950170-25-069396.txt |  | 9224512

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | agen-20250331.xsd | EX-101.SCH | 1285477
85 | EXTRACTED XBRL INSTANCE DOCUMENT | agen-20250331_htm.xml | XML | 1783331

Mailing Address 3 FORBES ROAD LEXINGTON MA 02421
Business Address 3 FORBES ROAD LEXINGTON MA 02421 781-674-4410
AGENUS INC (Filer) CIK: 0001098972 (see all company filings)

EIN.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29089 | Film No.: 25935688
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)